Literature DB >> 12200363

In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.

Paula Río1, José Carlos Segovia, Helmut Hanenberg, José Antonio Casado, Jesús Martínez, Kerstin Göttsche, Ngan Ching Cheng, Henri J Van de Vrugt, Fré Arwert, Hans Joenje, Juan A Bueren.   

Abstract

Fanconi anemia (FA) is a rare autosomal recessive disease, characterized by bone marrow failure and cancer predisposition. So far, 8 complementation groups have been identified, although mutations in FANCA account for the disease in the majority of FA patients. In this study we characterized the hematopoietic phenotype of a Fanca knockout mouse model and corrected the main phenotypic characteristics of the bone marrow (BM) progenitors using retroviral vectors. The hematopoiesis of these animals was characterized by a modest though significant thrombocytopenia, consistent with reduced numbers of BM megakaryocyte progenitors. As observed in other FA models, the hematopoietic progenitors from Fanca(-/-) mice were highly sensitive to mitomycin C (MMC). In addition, we observed for the first time in a FA mouse model a marked in vitro growth defect of Fanca(-/-) progenitors, either when total BM or when purified Lin(-)Sca-1(+) cells were subjected to in vitro stimulation. Liquid cultures of Fanca(-/-) BM that were stimulated with stem cell factor plus interleukin-11 produced low numbers of granulocyte macrophage colony-forming units, contained a high proportion of apoptotic cells, and generated a decreased proportion of granulocyte versus macrophage cells, compared to normal BM cultures. Aiming to correct the phenotype of Fanca(-/-) progenitors, purified Lin(-)Sca-1(+) cells were transduced with retroviral vectors encoding the enhanced green fluorescent protein (EGFP) gene and human FANCA genes. Lin(-)Sca-1(+) cells from Fanca(-/-) mice were transduced with an efficiency similar to that of samples from wild-type mice. More significantly, transductions with FANCA vectors corrected both the MMC hypersensitivity as well as the impaired ex vivo expansion ability that characterized the BM progenitors of Fanca(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200363

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.

Authors:  Jennifer E Adair; Xin Zhao; Sylvia Chien; Min Fang; Martin E Wohlfahrt; Grant D Trobridge; Jason A Taylor; Brian C Beard; Hans-Peter Kiem; Pamela S Becker
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

Review 2.  Topics in pediatric leukemia--Fanconi's anemia: new insights.

Authors:  Noah Federman; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-04-06

Review 3.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

4.  Defective endomitosis during megakaryopoiesis leads to thrombocytopenia in Fanca-/- mice.

Authors:  Patrycja Pawlikowska; Pierre Fouchet; William Vainchenker; Filippo Rosselli; Valeria Naim
Journal:  Blood       Date:  2014-09-26       Impact factor: 22.113

Review 5.  Mouse models in hematopoietic stem cell gene therapy and genome editing.

Authors:  Stefan Radtke; Olivier Humbert; Hans-Peter Kiem
Journal:  Biochem Pharmacol       Date:  2019-11-06       Impact factor: 5.858

6.  Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice.

Authors:  Joanna M Prasher; Astrid S Lalai; Claudia Heijmans-Antonissen; Robert E Ploemacher; Jan H J Hoeijmakers; Ivo P Touw; Laura J Niedernhofer
Journal:  EMBO J       Date:  2005-02-03       Impact factor: 11.598

7.  Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766.

Authors:  Michael D Milsom; Andrew W Lee; Yi Zheng; Jose A Cancelas
Journal:  Haematologica       Date:  2009-06-02       Impact factor: 9.941

8.  Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.

Authors:  Ariana Jacome; Susana Navarro; Paula Río; Rosa M Yañez; Africa González-Murillo; M Luz Lozano; Maria Luisa Lamana; Julian Sevilla; Teresa Olive; Cristina Diaz-Heredia; Isabel Badell; Jesus Estella; Luis Madero; Guillermo Guenechea; José Casado; Jose C Segovia; Juan A Bueren
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

9.  An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.

Authors:  William Marion; Steffen Boettcher; Sonya Ruiz-Torres; Edroaldo Lummertz da Rocha; Vanessa Lundin; Vivian Morris; Stephanie Chou; Anna M Zhao; Caroline Kubaczka; Olivia Aumais; Yosra Zhang; Akiko Shimamura; Thorsten M Schlaeger; Trista E North; Benjamin L Ebert; Susanne I Wells; George Q Daley; R Grant Rowe
Journal:  Blood Adv       Date:  2020-10-13

Review 10.  TNF-α signaling in Fanconi anemia.

Authors:  Wei Du; Ozlem Erden; Qishen Pang
Journal:  Blood Cells Mol Dis       Date:  2013-07-24       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.